General Information of Drug (ID: DMNB4UJ)

Drug Name
ISIS 156475 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMNB4UJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 156452 DMCU6RF Discovery agent N.A. Investigative [1]
ISIS 156453 DMQ9018 Discovery agent N.A. Investigative [1]
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide DM0CWPX Discovery agent N.A. Investigative [2]
ISIS 156451 DMPH2W7 Discovery agent N.A. Investigative [1]
ISIS 156473 DMDFUS8 Discovery agent N.A. Investigative [1]
ISIS 156449 DMPB3FH Discovery agent N.A. Investigative [1]
ISIS 156474 DMCXP9T Discovery agent N.A. Investigative [1]
N-(1H-benzo[d]imidazol-2-yl)-3-cyanobenzamide DM054NF Discovery agent N.A. Investigative [2]
ISIS 156472 DM3U0Z6 Discovery agent N.A. Investigative [1]
ISIS 156471 DMM9ARP Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
IRAK4 messenger RNA (IRAK4 mRNA) TTILUKB IRAK4_HUMAN Not Available [1]

References

1 US patent application no. 6,692,959, Antisense modulation of IL-1 receptor-associated kinase-4 expression.
2 Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5.